Management of NCD

Management of NCD

Conor Ashleigh
© Credits

Overview

Noncommunicable disease (NCD) management is critical to achieving the global target of a 25% reduction in premature mortality by 2025 and the SDG goal of a one-third reduction by 2030. ​ As of 2021, 9.5 million people died of noncommunicable diseases (males 4.7 million; females 4.8 million).​

NCD management includes screening, detection and treatment of the diseases, as well as palliative care for those in need. ​

NCD management interventions are critical for achieving the global target of a 25% relative reduction in the risk of premature mortality from NCDs by 2025, and the SDG target of a one-third reduction in premature deaths from NCDs by 2030. The Objective 4 of Global action plan for prevention and control of NCDs 2013-2030 seeks to “strengthen and orient health systems to address the prevention and control of NCDs and the underlying social determinants through people-centred primary health care and universal health coverage”. Effective NCD control, aligned with Universal Health Coverage, requires accessible and affordable services, evidence-based guidelines, essential medicines, trained health workers, and robust information systems at the primary health care level. ​

The WHO South-East Asia Regional Strategy for comprehensive cancer prevention and management 2024–2030, approved by the Seventy-seventh session of Regional Committee is developed to serve as a guide to promote a contextualized, evidence-based approach to cancer control, leveraging support from the global initiatives on cancer.​

WHO South-East Asia Response​

WHO SE Asia Regional Office works with Member States and partners to improve NCD care services as a public health priority. Implementation roadmap for accelerating the prevention and control of noncommunicable diseases in South-East Asia 2022-2030 provides strategic directions and tools with a view to prioritizing and accelerating high-impact interventions that are feasible within the national context. It provides guidance for prevention and control of NCDs, including links and tools for easy access. homev2 | WHO South-East Asia Regional NCD Roadmap

The Seventy-sixth session of WHO SE Asia Regional Committee in 2023 adopted the Resolution on ‘SEAHEARTS: Accelerating prevention and control of cardiovascular diseases in the South-East Asia Region (SEA/RC76/R5)’ . The resolution aims to accelerate the national responses with time-bound commitments to improve treatment coverage of hypertension and diabetes in primary health care along with reduction of risk factors.

Key facts

  • Hypertension is leading attributable risk factor for NCDs in the region. Every 1 in 3 adults is suffering from hypertension in the region. High systolic blood pressure is responsible for 2.4 million deaths in the region (around 25% of all global deaths due to high systolic blood pressure). ​
  • Prevalence of hypertension among adults aged 30–79 is estimated to be above 32.57% indicating more than 294 million people with hypertension in the region in 2019​
  • The hypertension care case cascade indicates that more than 61% are undiagnosed, and only 29% are on treatment and less than 14% have controlled status among hypertensive population in the region​
  • Over 276 million adults aged 18 years and above are suffering from diabetes in WHO SE Asia Region as per 2022 Global Health estimates.​
  • Alarmingly, more than 50% of people with diabetes are unaware of their condition, and it is estimated that over 177 million individuals living with diabetes in the region are not receiving treatment​
  • In 2021, chronic respiratory diseases caused approximately 1.56 million deaths in the region, with COPD accounting for nearly 1.24 million and asthma for 254,834 deaths. Approximately 37% of these deaths occurred before the age of 70.​
  • The prevalence of chronic respiratory diseases for the SE Asia Region as 4.73% affecting over 104 million individuals​
  • WHO Package of essential noncommunicable (PEN) disease interventions for primary health care is a framework for strengthening the equity and efficiency of primary health care in low-resource settings for the integrated management of NCDs.​
  • The HEARTS technical package provides a strategic approach to improving cardiovascular health in countries in primary care settings.​
SEAHEARTS: Accelerating prevention and control of cardiovascular diseases in the South-East Asia Region

Cardiovascular diseases (CVD) are a leading cause of mortality and morbidity in the WHO South-East (SE) Asia Region. Global Health Estimates of 2021 indicated...

Third Regional Consultation on SEAHEARTS: Extended and Expanded Milestones 203025 September 2025 | 09:30- 11:30 ISTThe Third Regional Consultation on SEAHEARTS:...

Chronic respiratory diseases (CRDs) – primarily chronic obstructive pulmonary disease (COPD) and asthma – are a major and growing public health...

Noncommunicable diseases (NCDs), impose a major and growing burden on health and development in the South-East (SE) Asia Region. The region comprises...

Eradicating cervical cancer in Thailand: A journey of hope and progress

Thailand has made significant progress in cervical cancer control and is on track to achieve the 90-70-90 targets by 2030, particularly through HPV vaccination...

The Second Regional Consultation on the SEAHEARTS: Accelerating prevention and controlof CVDs in the South-East Asia Region (SEA/RC76/R5) initiative was...

Globally, around 828 million people have diabetes, and two million deaths are attributed to diabetes every year. In the WHO South-East Asia (SE Asia) Region,...

A stroke is a serious life-threatening medical condition that occurs when the blood supply to a part of the brain is cut off. Stroke is one of the...

Flip Chart

All →

Related health topics